The magnetic resonance imaging group is interested in new magnetic resonance (MR) technologies for the assessment of acute and chronic central nervous system (CNS) disorders with focus on multiple sclerosis, stroke syndromes, subcortical and cortical dementias. In this context the group has applied new methods, such as sodium 23Na MR imaging, developed and performed the MR assessment of the slow diffusion components by Q-space imaging as a more specific approach to detect tissue changes in the normal appearing white matter, applied ASL perfusion imaging and performed non-localised whole brain N-acetylaspartate (NAA) measurements in order to evaluate new pathophysiological aspects of acute and degenerative pathologies.